BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND FAS, FAS1, 355, ENSG00000026103, FASTM, APO-1, P25445, CD95, ALPS1A, TNFRSF6, APT1 AND Treatment
142 results:

  • 1. Effectiveness of endovascular treatment for in-hospital stroke vs. community-onset stroke: a propensity score-matched analysis.
    Jung JW; Kim KH; Yun J; Nam HS; Heo JH; Baik M; Yoo J; Kim J; Park H; Sohn SI; Hong JH; Kim BM; Kim DJ; Heo J; Bang OY; Seo WK; Chung JW; Lee KY; Jung YH; Lee HS; Ahn SH; Shin DH; Choi HY; Cho HJ; Baek JH; Kim GS; Seo KD; Kim SH; Song TJ; Han SW; Park JH; Choi JK; Kim YD;
    J Neurol; 2024 May; 271(5):2684-2693. PubMed ID: 38376545
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. SKYSCRAPER-02: Tiragolumab in Combination With Atezolizumab Plus Chemotherapy in Untreated Extensive-Stage Small-Cell Lung cancer.
    Rudin CM; Liu SV; Soo RA; Lu S; Hong MH; Lee JS; Bryl M; Dumoulin DW; Rittmeyer A; Chiu CH; Ozyilkan O; Johnson M; Navarro A; Novello S; Ozawa Y; Tam SH; Patil NS; Wen X; Huang M; Hoang T; Meng R; Reck M
    J Clin Oncol; 2024 Jan; 42(3):324-335. PubMed ID: 37976444
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Inhibition of extranodal NK/T-cell lymphoma by Chiauranib through an AIF-dependent pathway and its synergy with L-asparaginase.
    Gao T; Huang J; Yin H; Huang J; Xie J; Zhou T; Fan W; Yang X; Gao G; Li Z
    Cell Death Dis; 2023 May; 14(5):316. PubMed ID: 37160920
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Afatinib in Untreated Stage IIIB/IV Lung Adenocarcinoma with Major Uncommon Epidermal Growth Factor Receptor (EGFR) Mutations (G719X/L861Q/S768I): A Multicenter Observational Study in Taiwan.
    Hsu PC; Lee SH; Chiu LC; Lee CS; Wu CE; Kuo SC; Ju JS; Huang AC; Li SH; Ko HW; Yang CT; Wang CC
    Target Oncol; 2023 Mar; 18(2):195-207. PubMed ID: 36805452
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The Pakistan brain Tumour Epidemiology Study.
    Enam SA; Shah MM; Bajwa MH; Khalid MU; Bakhshi SK; Baig E; Altaf IA; Laghari AA; Anis SB; Akhunzada NZ; Raghib MF; Gilani JA; Jawed N; ; Siddiqi S;
    J Pak Med Assoc; 2022 Nov; 72(Suppl 4)(11):S4-S11. PubMed ID: 36591621
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Detection and evolutionary dynamics of somatic fas variants in autoimmune lymphoproliferative syndrome: Diagnostic implications.
    Batlle-Masó L; Garcia-Prat M; Parra-Martínez A; Franco-Jarava C; Aguiló-Cucurull A; Velasco P; Antolín M; Rivière JG; Martín-Nalda A; Soler-Palacín P; Martínez-Gallo M; Colobran R
    Front Immunol; 2022; 13():1014984. PubMed ID: 36466883
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Effectiveness of Antiseizure Medication Duotherapies in Patients With Glioma: A Multicenter Observational Cohort Study.
    van der Meer PB; Dirven L; Fiocco M; Vos MJ; Kouwenhoven MCM; van den Bent MJ; Taphoorn MJB; Koekkoek JAF
    Neurology; 2022 Sep; 99(10):e999-e1008. PubMed ID: 36219797
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Radiotherapy activity in the COVID 19 pandemic: Brazil's operational national-level study.
    Moraes FY; Gouveia AG; Lima RP; Bratti VF; Hamamura AC; Viani GA
    J Cancer Policy; 2023 Jun; 36():100367. PubMed ID: 36216270
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Resistant prolactinomas: a case series of 26 patients.
    Eshkoli T; Fraenkel M; Zaid D; Cohen D; Yoel U; Tsvetov G; Gorshtein A; Goldbart A; Greenman Y; Shimon I
    Endocrine; 2022 Aug; 77(2):349-356. PubMed ID: 35604631
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Impact of Time to Diagnosis on Morbidity and Survival in Children With Malignant Central Nervous System Tumors.
    Ronsley R; Crowell C; Irvine M; Kang M; Goldman RD; Erker C; Cheng S
    J Pediatr Hematol Oncol; 2023 Mar; 45(2):e188-e193. PubMed ID: 35129148
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. No difference in radiologic outcomes for natalizumab patients treated with extended interval dosing compared with standard interval dosing: Real-world evidence from MS PATHS.
    Ryerson LZ; Naismith RT; Krupp LB; Charvet LE; Liao S; Fisher E; de Moor C; Williams JR; Campbell N
    Mult Scler Relat Disord; 2022 Feb; 58():103480. PubMed ID: 35051898
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Analysis of risk factors and preventive strategies for intracranial infection after neuroendoscopic transnasal pituitary adenoma resection.
    Huang X; Zhang X; Zhou J; Li G; Zheng G; Peng L; Yan Z; Chen S
    BMC Neurosci; 2022 Jan; 23(1):1. PubMed ID: 34979913
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Heterogeneity of Response to Iron-Based Metallodrugs in Glioblastoma Is Associated with Differences in Chemical Structures and Driven by fas Expression Dynamics and Transcriptomic Subtypes.
    Vessières A; Quissac E; Lemaire N; Alentorn A; Domeracka P; Pigeon P; Sanson M; Idbaih A; Verreault M
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638742
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Management strategies for pediatric patients with tectal gliomas: a systematic review.
    Bauman MMJ; Bhandarkar AR; Zheng CR; Riviere-Cazaux C; Beeler CJ; Naylor RM; Daniels DJ
    Neurosurg Rev; 2022 Apr; 45(2):1031-1039. PubMed ID: 34609665
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Association of radiation dose intensity with overall survival in patients with distant metastases.
    Kao J; Farrugia MK; Frontario S; Zucker A; Copel E; Loscalzo J; Sangal A; Darakchiev B; Singh A; Missios S
    Cancer Med; 2021 Nov; 10(22):7934-7942. PubMed ID: 34595844
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Cognitive interference processing in adults with childhood craniopharyngioma using functional magnetic resonance imaging.
    Svärd D; Follin C; Fjalldal S; Hellerstedt R; Mannfolk P; Mårtensson J; Sundgren P; Erfurth EM
    Endocrine; 2021 Dec; 74(3):714-722. PubMed ID: 34292485
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Risks of recurrent stroke and all serious vascular events after spontaneous intracerebral haemorrhage: pooled analyses of two population-based studies.
    Li L; Poon MTC; Samarasekera NE; Perry LA; Moullaali TJ; Rodrigues MA; Loan JJM; Stephen J; Lerpiniere C; Tuna MA; Gutnikov SA; Kuker W; Silver LE; Al-Shahi Salman R; Rothwell PM
    Lancet Neurol; 2021 Jun; 20(6):437-447. PubMed ID: 34022170
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Assessing fatty acid-induced lipotoxicity and its therapeutic potential in glioblastoma using stimulated Raman microscopy.
    Yuan Y; Shah N; Almohaisin MI; Saha S; Lu F
    Sci Rep; 2021 Apr; 11(1):7422. PubMed ID: 33795756
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Radiotherapy Plus Procarbazine, Lomustine, and Vincristine Versus Radiotherapy Plus Temozolomide for IDH-Mutant Anaplastic Astrocytoma: A Retrospective Multicenter Analysis of the French POLA Cohort.
    Esteyrie V; Dehais C; Martin E; Carpentier C; Uro-Coste E; Figarella-Branger D; Bronniman C; Pouessel D; Ciron DL; Ducray F; Moyal EC; Network P
    Oncologist; 2021 May; 26(5):e838-e846. PubMed ID: 33524191
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Cedrol suppresses glioblastoma progression by triggering DNA damage and blocking nuclear translocation of the androgen receptor.
    Chang KF; Huang XF; Chang JT; Huang YC; Weng JC; Tsai NM
    Cancer Lett; 2020 Dec; 495():180-190. PubMed ID: 32987140
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 8.